Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Development of an Intraoperative Indicator of Pancreatic Leakage to Reduce Postoperative Pancreatic Fistula

Reference number
Coordinator Magle Aktiebolag - Magle AB
Funding from Vinnova SEK 1 088 500
Project duration August 2016 - August 2018
Status Completed

Purpose and goal

The purpose of the project was to develop a medical device that can prevent postoperative pancreatic fistula. The goal was that the product should be user-friendly, quickly and accurately visualize pancreatic leakage and thereby guide the surgeon to safer sealing. We have developed an indicator that visualizes pancreatic leakage within a minute of application. The product is non-toxic, easily broken down and eliminated by the body. We expect our indicator to reduce postoperative complications.

Expected results and effects

We have filed a patent application and received a first positive opinion. We have also done several in vivo and in vitro studies and have three scientific articles ready to be submitted. The first toxicological studies have shown positive results and we have begun the regulatory work. We expect our product to soon be used clinically, that it has potential for use in every pancreas surgery and that it significantly will reduce postoperative complications.

Planned approach and implementation

The reason we were able to keep our project plan depends on the combination of committed project workers and a standing dialogue with our German partner. This has minimized the waste of time as all progress generated by both parties has been addressed quickly between the two partners.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 2 December 2021

Reference number 2016-02304

Page statistics